Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
Saved in:
Main Author: | Frontiers Production Office (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
by: Fenge Jiang, et al.
Published: (2022) -
Erratum: Advances in RIPK1 kinase inhibitors
by: Frontiers Production Office
Published: (2023) -
Erratum: Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
by: Frontiers Production Office
Published: (2022) -
Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung Cancer
by: Anning Xiong, et al.
Published: (2022) -
Erratum: Necrotizing pneumonia in children: Chest computed tomography vs. lung ultrasound
by: Frontiers Production Office
Published: (2023)